Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Landau Uniforms Donates $600,000 in Scrubs to Haiti Relief

August 4, 2010 11:38 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn. , Aug. 4 /- Landau Uniforms, the nation's leading quality health care apparel manufacturer, has donated more than $600,000 worth of scrubs to aid Haiti relief efforts. "Landau is committed to providing ongoing, long-term support for Haiti as it struggles to recover from...

TOPICS:

New Program Makes Prosthetics Available to All Haitian Children Who Lost Limbs in Earthquake

August 4, 2010 11:38 am | by Bio-Medicine.Org | News | Comments

Knights of Columbus partners with Medishare to provide physical therapy and prosthetic limbs WASHINGTON , Aug. 4 /PRNewswire-USNewswire/ -- The Knights of Columbus today announced that it will come to the aid of every Haitian child who lost a limb in the January earthquake that destroyed...

TOPICS:

Daiichi Sankyo Settled Patent Litigation for Evoxac®

August 4, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J. , Aug. 4 /- Daiichi Sankyo, Inc. and its parent company, Daiichi Sankyo Co., Ltd, (collectively, "Daiichi Sankyo") have reached an agreement with Apotex Inc. and Apotex Corp. (collectively, "Apotex") to settle their patent litigation involving Apotex's challenge to...

TOPICS:
Advertisement

OvaGene Oncology Joins The Gynecologic Oncology Group (GOG) Industry Collaboration Team to Advance Gynecologic Cancer Research

August 4, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif. , Aug. 4 /- OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, is pleased to announce their partnership with The Gynecologic Oncology Group (GOG) through the...

TOPICS:

Scientists pinpoint 95 gene loci linked to lipid metabolism

August 4, 2010 10:38 am | by EurekAlert | News | Comments

(Helmholtz Zentrum München - German Research Center for Environmental Health) In a large-scale international study in which Helmholtz Zentrum Muenchen participated, scientists have identified 95 gene loci which influence lipoprotein metabolism in humans. Viewed from a long-term...

TOPICS:

UT Southwestern's cancer center earns National Cancer Institute designation

August 4, 2010 10:34 am | by EurekAlert | News | Comments

(UT Southwestern Medical Center) The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center has attained National Cancer Institute designation, an elite distinction held by only 65 other cancer centers nationwide.

TOPICS:

Parents should help teens get back on right sleep track

August 4, 2010 10:34 am | by Baylor College of Medicine | News | Comments

Computers, televisions and cell phones are preventing your teen from getting enough sleep, and that can affect grades and day to day life, said a sleep expert at Baylor College of Medicine . "Because teens tend to stay up and wake up later in the summer, their bodies get used to it,...

TOPICS:

Kahn Swick & Foti, LLC and Former Louisiana Attorney General Announce Class Complaint Against Almost Family, Inc. on Behalf of Shareholders Who Purchased Shares of AFAM From Novemb...

August 4, 2010 9:45 am | by The Associated Press | News | Comments

Kahn Swick & Foti, LLC ("KSF") (www.ksfcounsel.com (http://www.ksfcounsel.com) ), a nationally recognized Louisiana-based law firm, and KSF partner Charles C. Foti, Jr., former Attorney General of Louisiana, announce that a class action securities case was filed in the United States...

Advertisement

RehabCare 2Q earnings double but shares tumble

August 4, 2010 9:45 am | by The Associated Press | News | Comments

Rehabilitation services company RehabCare Group Inc. said its second-quarter earnings more than doubled, as revenue surged due to an acquisition.But the St. Louis company's performance fell short of analyst expectations, and the stock skidded in Wednesday afternoon trading.RehabCare said late...

FDA fast tracks Acceleron muscle disease drug target

August 4, 2010 9:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Acceleron Pharma Inc. has announced that it has received fast track designation from the U.S. Food and Drug Administration for a drug candidate designed to build muscle mass and strength in treating Duchenne Muscular Dystrophy, a fatal neuromuscular disease.

Tolerx names biotech vet de Fougerolles to chief scientist

August 4, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Tolerx Inc. has appointed Antonin de Fougerolles as chief scientific officer of the cancer, diabetes and autoimmune disease therapeutics firm. His role includeds overseeing the company's research and development and growing Tolerx's leadership in T cell immunology.

TOPICS:

Gene for Cholesterol and Cardiovascular Disease Identified through Genome Scan

August 4, 2010 9:35 am | by University Of Pennsylvania | News | Comments

Researchers have shown that a gene linked to a disease trait by genome wide association studies (GWAS) can be clinically relevant and an important determinant of disease risk. In a study published this week in Nature, a team of investigators describes how a region on chromosome 1...

TOPICS:

Technology transfer: 25 years at Baylor College of Medicine

August 4, 2010 9:33 am | by Baylor College of Medicine | News | Comments

The Baylor Licensing Group – the office responsible for transferring research results and discoveries developed by Baylor College of Medicine faculty to the marketplace – is celebrating 25 years at the College. More than 200 diagnostic, clinical and research products have...

TOPICS:

Gentiva Health Services selling $305M in debt

August 4, 2010 8:45 am | by The Associated Press | News | Comments

Home health services company Gentiva Health Services Inc. said Wednesday it plans to sell $305 million in debt in a private offering.The company will sell senior notes due in 2018 and put the proceeds toward its purchase of Odyssey HealthCare.Gentiva is buying Odyssey for $912 million, or $27...

Health Robotics Continues to Dominate I.V. Automation in America, With 11 New Contracts in Second Quarter 2010

August 4, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

BOZEN, SUD-TIROL, Italy , August 4, 2010 /- Health Robotics announced its second consecutive quarter's record-breaking results, as reported by our sales channel partner Health Robotics Canada Inc. (HRCI) since Health Robotics S.r.l. upgraded its American distribution channels this year....

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading